Loop Genomics

Loop Genomics Overview

Founded 2015
Founded
Status Private
Employees 6
Employees
Latest Deal Type Series A
Latest Deal Amount $9.2M
Latest Deal Amount
Investors 9

Loop Genomics General Information

Description

Developer of a long-read DNA sequencing technology designed to transforms any short read sequencer into a single molecule long-read sequencer. The company's technology encompasses consumables and analysis tools that are intended to address a wide range of genetic analysis solutions for research, diagnostics, agbio and industrial applications, enabling clients with accurate, long-read sequencing and single-molecule counting using a lab's existing sequencing hardware.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Loop Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 14-Feb-2018 $9.2M 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 00.000 Completed Startup
2. Early Stage VC 20-May-2016 $1.5M $1.62M Completed Startup
1. Accelerator/Incubator 23-Mar-2016 $120K $120K 00.000 Completed Startup

Loop Genomics Cap Table

To view Loop Genomics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A-1 1,214,181 $0.000010 $0.03 $0.41 $0.41 1x $0.41 5.21%
Series A 6,861,063 $0.000010 $0.09 $1.17 $1.17 1x $1.17 24.88%

Loop Genomics Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Nabsys Venture Capital-Backed Providence, RI 00 0000 0000000000 0 0000
0000 0000000 Corporate Backed or Acquired Constance, Germany 000 000000&0
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000 Corporation Woburn, MA 00 000 00000000
0000 Private Equity-Backed Longmont, CO 00000 0000000 0000 00000

Loop Genomics Executive Team (2)

Name Title Board Seat Contact Info
Tuval Ben-Yehezkel Ph.D Founder, Board Member, President & Chief Executive Officer
Tony Lialin Chief Commercial Officer

Loop Genomics Investors (9)

To view Loop Genomics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DN Capital Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
Rising Tide Fund Venture Capital Minority 000 0000 000000 0
Wisemont Capital Venture Capital Minority 000 0000 000000 0
11.2 Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial